Harvard Bioscience (HBIO) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Harvard Bioscience (HBIO) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.20 Bn | 220.14 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 142.51 Bn | 138.16 Bn | 3.61 Bn | 59.25% |
| 3 | Agilent Technologies | 40.40 Bn | 38.64 Bn | 1.04 Bn | 8.50% |
| 4 | Illumina | 30.73 Bn | 29.57 Bn | 770.00 Mn | -8.41% |
| 5 | Revvity | 13.63 Bn | 12.61 Bn | 416.87 Mn | 1.16% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 180.15% |
| 7 | Bio-Rad Laboratories | 10.01 Bn | 8.39 Bn | 345.80 Mn | 18.96% |
| 8 | Repligen | 9.21 Bn | 8.20 Bn | 110.04 Mn | -66.42% |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn | -149.43% |
| 10 | Harvard Bioscience | 35.61 Mn | 29.11 Mn | 12.63 Mn | -24.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.71% |
| Mar 31, 2026 | 93.29% |
| Dec 31, 2025 | 155.19% |
| Sep 30, 2025 | 74.85% |
| Jun 30, 2025 | 22.16% |
| Mar 31, 2025 | -954.59% |
| Dec 31, 2024 | 273.64% |
| Sep 30, 2024 | -279.34% |
| Jun 30, 2024 | -186.23% |
| Mar 31, 2024 | -850.45% |
| Dec 31, 2023 | -396.80% |
| Sep 30, 2023 | 64.51% |
| Jun 30, 2023 | -139.25% |
| Mar 31, 2023 | 108.63% |
| Dec 31, 2022 | -1.26% |
| Sep 30, 2022 | -1,860.46% |
| Jun 30, 2022 | 677.34% |
| Mar 31, 2022 | -892.67% |
| Dec 31, 2021 | -61.90% |
| Sep 30, 2021 | 85.21% |